Medicare Enrolled

Dr. Arthur Gelb, M.D.

Pulmonary Disease · Lakewood, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3650 SOUTH ST, Lakewood, CA 90712
5626332275
In practice since 2007 (19 years)
NPI: 1558481291 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gelb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gelb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gelb

Dr. Arthur Gelb is a pulmonary disease specialist in Lakewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gelb performed 3,018 Medicare services across 941 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gelb received a total of $21,441 from 35 pharmaceutical and/or device companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gelb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in CA $21,441 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,018
Medicare services
Top 11% in CA for pulmonary disease
941
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,212 $99 $150
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
1,064 $177 $330
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
174 $105 $165
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
129 $145 $315
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
106 $22 $80
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
99 $108 $280
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
37 $32 $120
Exhaled air test for lung function
A test that measures exhaled air to evaluate lung function while at rest and during exercise.
35 $45 $80
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
35 $47 $80
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
35 $49 $80
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $139 $290
Emergent tracheostomy
An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope.
19 $115 $250
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
19 $26 $70
Bronchoscopy
A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways.
18 $108 $500
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
15 $10 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,441
Total received (2018-2024)
Avg $3,063/year across 7 years
Top 9% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
523
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,214 (80.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,227 (19.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,563
2023
$1,973
2022
$1,881
2021
$1,484
2020
$1,168
2019
$1,961
2018
$10,411

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$471
Insmed, Inc.
$371
AstraZeneca Pharmaceuticals LP
$332
Mylan Specialty L.P.
$303
Regeneron Healthcare Solutions, Inc.
$290
GENZYME CORPORATION
$285
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
Electromed, Inc.
$125
ABBVIE INC.
$64
United Therapeutics Corporation
$49
PFIZER INC.
$27
Merck Sharp & Dohme LLC
$23
Janssen Pharmaceuticals, Inc
$20
Harmony Biosciences Llc
$11
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,698
Mylan Specialty L.P.
$5,351
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,698
GlaxoSmithKline, LLC.
$2,088
Regeneron Healthcare Solutions, Inc.
$1,098
GENZYME CORPORATION
$728
Insmed, Inc.
$474
United Therapeutics Corporation
$389
Genentech USA, Inc.
$211
Electromed, Inc.
$163
Gilead Sciences, Inc.
$160
Sunovion Pharmaceuticals Inc.
$146
Philips Electronics North America Corporation
$141
Merck Sharp & Dohme Corporation
$140
ABBVIE INC.
$129
Actelion Pharmaceuticals US, Inc.
$115
Circassia Pharmaceuticals Inc
$102
Janssen Pharmaceuticals, Inc
$93
Pulmonx Corporation
$76
La Jolla Pharmaceutical Company
$46
Baxter Healthcare
$46
Allergan, Inc.
$44
ABIOMED
$40
Olympus Corporation of the Americas
$40
Mallinckrodt Hospital Products Inc.
$30
PFIZER INC.
$27
Medtronic, Inc.
$23
Merck Sharp & Dohme LLC
$23
SANOFI-AVENTIS U.S. LLC
$21
Nabriva Therapeutics, plc
$21
Advanced Respiratory, Inc
$19
Allergan Inc.
$18
Alexion Pharmaceuticals, Inc.
$15
Inogen, Inc.
$13
Harmony Biosciences Llc
$11
Top 3 companies account for 68.8% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) InCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · DUPIXENT · Dymista · FARXIGA · FASENRA · GIAPREZA · Hillrom - Life 2000 Ventilation System · ILLUMISITE · Impella · InogenOne · LONHALA MAGNAIR · Letairis · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus Bronchoscopes · PREVNAR 20 · Perforomist · RECARBRIO · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The VitalCough System · Trilogy 100 · UPTRAVI · Utibron · WAKIX · WINREVAIR · XARELTO · Xenleta · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pulmonary disease in CA.

Looking for a pulmonary disease specialist in Lakewood?
Compare pulmonary diseases in the Lakewood area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
302
Per 100K population
3.1
County median income
$87,760
Nearest hospital
UCI HEALTH-LAKEWOOD
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gelb is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gelb experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Gelb performed 1,212 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gelb receive payments from pharmaceutical companies?
Yes. Dr. Gelb received a total of $21,441 from 35 companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gelb's costs compare to other pulmonary diseases in Lakewood?
Dr. Gelb's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gelb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →